HIV+ APOE4 carriers are at risk for neurocognitive impairment due to greater disease severity and CSF inflammation.

TitleHIV+ APOE4 carriers are at risk for neurocognitive impairment due to greater disease severity and CSF inflammation.
Publication TypePresentation
Year of Publication2015
AuthorsThames, AD, Briones, MS, Magpantay, LI, Singer, EJ, Martínez-Maza, O, Panos, SE, Hinkin, CH, Levine, AJ
Other NumbersPresented at the 21st meeting for the Society for Neuroimmune Pharmacology, Miama, FL, April 22-25, 2015